Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medamicus/Biomec

This article was originally published in The Gray Sheet

Executive Summary

Cardiac rhythm management and neuromodulation device lead and accessory supplier Biomec Cardiovascular, Inc. (BCI) will be acquired by percutaneous delivery system maker Medamicus for $18 mil. in cash and stock under a July 22 agreement. The deal will expand Medamicus' technology and OEM customer base, which includes Guidant, Medtronic, St. Jude, Cook and Bard. BCI sales "more than doubled" to $4.5 mil. for the first half of 2003, Medamicus notes. The firm simultaneously reported its second quarter sales from continuing operations of $4.3 mil., off 1%, in part due to decreased sales of advanced delivery systems. Trouble with the resin used in FlowGuard valved introducers also led the firm to suspend shipments of the device during the quarter; a re-launch is not expected until "late in the fourth quarter or early 2004," Medamicus says...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT018777

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel